T001: FDG-PET and serum TARC levels after one cycle of BV-AVD in advanced stage Hodgkin lymphoma patients: results from the very early PET-response adapted EORTC-COBRA trial

por Diepstra, Arjan, Visser, Lydia, Fortpied, Catherine, Noordzij, Walter, Loft, Annika, Arens, Anne, Sureda-Balari, Anna, Carvalho, Susana, Vranovský, Andrej, Sents, Ward, Buhrer, Emanuel, Plattel, Wouter J., Hutchings, Martin
Publicado 2022

Prospective Pilot Study of Telehealth As Domiciliary Follow-up after Hematopoietic Cell Transplantation during the COVID19 Pandemic

por Mussetti, Alberto, Salas Gay, Maria Queralt, Condom, Maria, Antonio, Maite, Ochoa, Cristian, Ivan, Iulia, Jiménez Ruiz De La Torre, David, Sanz-Linares, Gabriela Isabel, Ansoleaga, Belen, Parody, Rocio, Bazarbachi, Ali, Sureda Balari, Anna
Publicado 2020

Results of an Early Access Treatment Protocol of Daratumumab Monotherapy in Spanish Patients With Relapsed or Refractory Multiple Myeloma

por Alegre, Adrián, de la Rubia, Javier, Sureda Balari, Anna, Encinas Rodríguez, Cristina, Suárez, Alexia, Blanchard, María Jesús, Bargay Lleonart, Joan, Rodríguez-Otero, Paula, Insunza, Andrés, Palomera, Luis, Peñarrubia, María Jesús, Ríos-Tamayo, Rafael, Casado Montero, Luis Felipe, González, Marta Sonia, Potamianou, Anna, Couturier, Catherine, Pei, Huiling, Hevia, Henar, Milionis, Iordanis, Gaudig, Maren, Mateos, María-Victoria
Publicado 2020

Prospective Multicentric Observational Study of COVID19 in Oncohematological Patients in the Catalonia Region: The Opposite Effect of Steroids on Survival

por Mussetti, Alberto, Maluquer, Clara, Tebe Cordomi, Cristian, Condom, Maria, Molina-Mata, Kevin, Marin Jimenez, Juan Antonio, Tapia Tapia, Jose Carlos, Gavira Diaz, Javier, Majem Tarruella, Margarita, Falgas, Felip, Llobera Rius, Laia, Fort Culillas, Roser, Llavata Martí, Lucia, Moreno, Miriam, Vives, Susana, Coll, Rosa, Martin Batista, Silvia, Talarn, Carme, Sagüés, Miguel, Bazarbachi, Ali, Salazar, Ramon, Sureda Balari, Anna
Publicado 2020

Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS

por Moreau, Philippe, Chari, Ajai, Oriol, Albert, Martinez-Lopez, Joaquin, Haenel, Mathias, Touzeau, Cyrille, Ailawadhi, Sikander, Besemer, Britta, de la Rubia Comos, Javier, Encinas, Cristina, Mateos, Maria-Victoria, Salwender, Hans, Rodriguez-Otero, Paula, Hulin, Cyrille, Karlin, Lionel, Sureda Balari, Anna, Bargay, Joan, Benboubker, Lotfi, Rosiñol, Laura, Tarantolo, Stefano, Terebelo, Howard, Yang, Shiyi, Wang, Jianping, Nnane, Ivo, Qi, Ming, Kosh, Michele, Delioukina, Maria, Goldschmidt, Hartmut
Publicado 2023

T098: Brentuximab Vedotin plus ESHAP (BRESHAP) versus ESHAP in Patients with Relapsed or Refractory Classical Hodgkin’s Lymphoma. Interim Results of the BRESELIBET Prospective Clin...

por Sureda-Balari, Anna, Terol, M. José, Domingo-Domènech, Eva, Rodriguez, Ana Pilar González, Mohedo, Francisca Hernández, Céspedes, Javier Núñez, De La Cruz Vicente, Fátima, Muñoz, Carmen Martínez, Díaz, M. Elena Amutio, Córdoba, Raul, Izquierdo, Antonia Rodríguez, Domínguez, Samuel Romero, Meijide, Javier Briones, Greil, Richard, Velázquez, Miriam Moreno, Rubio, Araceli, Oteiro, Mariana Bastos, Gómez, Pilar, Avivi, Irit, Casanova, María, Del Campo García, Raquel, Noriega, Victor, Blanco, José Javier Sánchez, Sanz, Ramón. García
Publicado 2022